AJP - Cell Physiology, Vol 262, Issue 3 C708-C713, Copyright © 1992 by American Physiological Society

ARTICLES

U46619, a thromboxane A2 agonist, inhibits KCa channel activity from pig coronary artery

F. S. Scornik and L. Toro
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030.

Thromboxane A2 (TxA2) is a potent vasoconstrictor derived from the metabolism of arachidonic acid. Because potassium channels are involved in the contraction of vascular smooth muscle, their blockade could contribute to the TxA2-induced contraction. To test this possibility, we studied the effect of the TxA2 stable analogue U46619 on calcium-activated potassium (KCa) channels from coronary artery reconstituted into lipid bilayers. Addition of U46619 (50-150 nM) to the external but not to the internal side of the channel decreased the channel open probability (Po) between 15 and 80% of the control value. The inhibitory effect of U46619 affected both the open and closed states of the channel and could be reversed by internal calcium. Thromboxane B2, the inactive hydrolysis derivative of TxA2, did not affect channel activity. SQ 29548, a TxA2 receptor antagonist, was able to prevent the inhibition by U46619. Furthermore, SQ 29548 added after U46619 could restore channel activity to near control values. These results suggest that TxA2 could be a regulatory factor of KCa channels from coronary smooth muscle and that this regulation could be related to its action as a vasoconstrictor.

This article has been cited by other articles:

				N. J. Rusch BK channels in cardiovascular disease: a complex story of channel dysregulation Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1580 - H1582. [Full Text] [PDF]

				J. Ledoux, M. E. Werner, J. E. Brayden, and M. T. Nelson Calcium-Activated Potassium Channels and the Regulation of Vascular Tone Physiology, February 1, 2006; 21(1): 69 - 78. [Abstract] [Full Text] [PDF]

				F. S. Walters, M. Covarrubias, and J. S. Ellingson Potent inhibition of the aortic smooth muscle maxi-K channel by clinical doses of ethanol Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1107 - C1115. [Abstract] [Full Text] [PDF]

				S. Doi, D. S. Damron, K. Ogawa, S. Tanaka, M. Horibe, and P. A. Murray K+ channel inhibition, calcium signaling, and vasomotor tone in canine pulmonary artery smooth muscle Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L242 - L251. [Abstract] [Full Text] [PDF]

				N. I. Gokina and J. A. Bevan Histamine-induced depolarization: ionic mechanisms and role in sustained contraction of rabbit cerebral arteries Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2094 - H2104. [Abstract] [Full Text] [PDF]

				J. Kawasaki, K. Hirano, J. Nishimura, M. Fujishima, and H. Kanaide Mechanisms of Vasorelaxation Induced by Troglitazone, a Novel Antidiabetic Drug, in the Porcine Coronary Artery Circulation, December 1, 1998; 98(22): 2446 - 2452. [Abstract] [Full Text] [PDF]

				Y. Liu, A. G. Hudetz, H.-G. Knaus, and N. J. Rusch Increased Expression of Ca2+-Sensitive K+ Channels in the Cerebral Microcirculation of Genetically Hypertensive Rats : Evidence for Their Protection Against Cerebral Vasospasm Circ. Res., April 6, 1998; 82(6): 729 - 737. [Abstract] [Full Text] [PDF]

				J. Xia and B. R. Duling Patterns of excitation-contraction coupling in arterioles: dependence on time and concentration Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H323 - H330. [Abstract] [Full Text] [PDF]

				Q. J. Li and L. J. Janssen Membrane currents in canine bronchial artery and their regulation by excitatory agonists Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1358 - L1365. [Abstract] [Full Text] [PDF]